Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Astrana Health Q4 2024 GAAP EPS $(0.15) Misses $0.11 Estimate, Sales $665.20M Beat $617.24M Estimate

Author: Benzinga Newsdesk | February 27, 2025 04:34pm
Astrana Health (NASDAQ:ASTH) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $0.11 by 236.36 percent. This is a 157.69 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $665.20 million which beat the analyst consensus estimate of $617.24 million by 7.77 percent. This is a 88.42 percent increase over sales of $353.04 million the same period last year.

Posted In: ASTH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist